IBIO, INC. Public Float
IBIO, INC. (IBIO) had Public Float of $57.51 million as of 2025-12-31, per its 10-K filed 2026-08-28.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-08-28
- 2025-12-31: Entity Public Float $57.51M.
- 2024-12-31: Entity Public Float $22.43M.
- 2023-12-31: Entity Public Float $4.43M.
- 2022-12-31: Entity Public Float $5.44M.
| Period end | Entity Public Float |
|---|---|
| 2025-12-31 | $57.51M 10-K · filed 2026-08-28 |
| 2024-12-31 | $22.43M 10-K · filed 2025-09-05 |
| 2023-12-31 | $4.43M 10-K/A · filed 2024-09-24 |
| 2022-12-31 | $5.44M 10-K · filed 2023-09-27 |
| 2021-12-31 | $119.73M 10-K · filed 2022-10-11 |
| 2020-12-31 | $222.36M 10-K · filed 2021-09-28 |
| 2019-12-31 | $13.64M 10-K · filed 2020-10-13 |
| 2018-12-31 | $7.28M 10-K · filed 2019-08-26 |
| 2017-12-29 | $12.04M 10-K · filed 2018-09-18 |
| 2016-12-30 | $21.26M 10-K · filed 2017-09-15 |
| 2015-12-31 | $3.01M 10-K · filed 2016-10-13 |
| 2014-12-31 | $33.20M 10-K · filed 2015-10-13 |
| 2013-12-31 | $11.54M 10-K · filed 2014-09-29 |
| 2012-12-31 | $18.25M 10-K/A · filed 2013-10-04 |
| 2012-06-30 | $22.34M 10-K/A · filed 2012-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |